23 May 2013
Keywords: OSI Pharma, Astellas, M&A, Tarceva, White knight
Article | 16 March 2010
US drugmaker OSI Pharmaceuticals has formally rejected a $3.5-billion takeover bid from Japanese drug major Astellas, telling shareholders yesterday that ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 March 2010
17 March 2010
© 2013 thepharmaletter.com